Searches like how GLP-1 drugs differ mechanism show that while the core function is similar, differences in formulation and additional mechanisms can impact effectiveness
Some brands focus on weight management programs that combine prescriptions, medical oversight, and tools that support long-term results
Last reviewed: May 24, 2026 Last updated: May 24, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
PI3K activates protein kinase B (Akt), which inactivates several important substrate proteins, such as glycogen synthase kinase 3 (GSK-3) 18 and forkhead box O, 19 and activates mammalian target of rapamycin (mTOR)
Experience personalized, compassionate care designed to support long-term wellness and vitality
Someone starting at 300 pounds might lose 45 pounds (15%), while someone starting at 180 pounds might lose 27 pounds (15%)